-+ 0.00%
-+ 0.00%
-+ 0.00%

Ocular Therapeutix Q1 EPS $(0.38) Misses $(0.29) Estimate, Sales $10.70M Miss $16.83M Estimate

Benzinga·05/05/2025 11:06:30
Listen to the news
Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.29) by 31.03 percent. This is a 35.71 percent decrease over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $10.70 million which missed the analyst consensus estimate of $16.83 million by 36.44 percent. This is a 27.59 percent decrease over sales of $14.77 million the same period last year.